VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 29 filers reported holding VTV THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $57,000 | +111.1% | 20,365 | +39.2% | 0.00% | – |
| Q4 2020 | $27,000 | +3.8% | 14,635 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | -21.2% | 14,635 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | -28.3% | 14,635 | +30.5% | 0.00% | – |
| Q1 2018 | $46,000 | -31.3% | 11,218 | 0.0% | 0.00% | – |
| Q4 2017 | $67,000 | -10.7% | 11,218 | -10.4% | 0.00% | – |
| Q3 2017 | $75,000 | +21.0% | 12,518 | 0.0% | 0.00% | – |
| Q2 2017 | $62,000 | -39.8% | 12,518 | -20.4% | 0.00% | – |
| Q1 2017 | $103,000 | +33.8% | 15,718 | -1.3% | 0.00% | – |
| Q4 2016 | $77,000 | -32.5% | 15,918 | 0.0% | 0.00% | – |
| Q3 2016 | $114,000 | +22.6% | 15,918 | -0.6% | 0.00% | – |
| Q2 2016 | $93,000 | +34.8% | 16,018 | +19.7% | 0.00% | – |
| Q1 2016 | $69,000 | -11.5% | 13,386 | +17.4% | 0.00% | – |
| Q4 2015 | $78,000 | +6.8% | 11,400 | +1.8% | 0.00% | – |
| Q3 2015 | $73,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $1,491,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 117,400 | $583,000 | 0.04% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 39,779 | $198,000 | 0.03% |
| Candriam S.C.A. | 140,000 | $696,000 | 0.01% |
| Alyeska Investment Group, L.P. | 204,523 | $1,016,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11,396 | $57,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $373,000 | 0.00% |
| FRANKLIN RESOURCES INC | 899,100 | $4,469,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 264,214 | $1,313,000 | 0.00% |
| SG Americas Securities, LLC | 12,845 | $64,000 | 0.00% |